Gastrointestinal Bleeding Risk with Apixaban

Mechanism of Risk

The American College of Cardiology notes that anticoagulants increase the risk of gastrointestinal bleeding approximately 3 times when combined with nonsteroidal anti-inflammatory drugs (NSAIDs) 1, 2
The European Society of Cardiology states that this risk is due to anticoagulants preventing normal hemostasis in ulcers or erosions that already exist due to other causes 1
The International Society on Thrombosis and Haemostasis reports that the INR may increase up to 15% when anticoagulants are combined with NSAIDs 2

The American Heart Association recommends that patients with a history of gastrointestinal bleeding should avoid NSAIDs completely, as this is the most important risk factor (OR 13.5), increasing the risk 2.5-4 times 1, 3
The American College of Gastroenterology states that concomitant use of anticoagulants and NSAIDs increases the risk of bleeding 3-6 times 2
The European Society of Cardiology notes that age >65 years + anticoagulation increases the risk 2-3.5 times 1, 3

The American College of Cardiology recommends that patients with apixaban who require NSAIDs should use alternative analgesics, such as acetaminophen or corticosteroids, if possible 4, 5
The International Society on Thrombosis and Haemostasis suggests that if NSAIDs are necessary, a COX-2 inhibitor + proton pump inhibitor (PPI) should be used, although this combination has not been clinically proven 5
The American Heart Association states that IBPs reduce the risk of bleeding ulcers in 75-85% of high-risk users 1, 3

The American Society of Anesthesiologists recommends acetaminophen IV 1 gram every 6 hours as an effective and safe alternative for pain management in patients with apixaban 3
The American Pain Society suggests multimodal analgesia, combining acetaminophen with regional techniques to reduce opioid requirements 3
The European Society of Regional Anaesthesia notes that low-dose ketamine (0.25 mg/kg/h) is valuable for severe pain, particularly in patients with multiple gastrointestinal risk factors 3

The American College of Cardiology warns against underestimating the risk of over-the-counter NSAIDs, as patients often combine prescribed NSAIDs with over-the-counter NSAIDs, dramatically increasing the risk 6, 7
The American Gastroenterological Association advises against assuming that COX-2 inhibitors are safe without gastroprotection, as they lose their gastrointestinal safety advantage when combined with anticoagulants 6, 1